• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Osteoporosis, Postmenopausal

Osteoporosis, Postmenopausal - 28 Studies Found

Not yet recruiting : The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)
: Postmenopausal Osteoporosis
: 2016-07-19
:
  • Drug: Deferasirox and calcium-vitamin D3

Completed : Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
: Postmenopausal Osteoporosis
: 2004-09-17
:
  • Drug: AMG 162 60 mg/mL denosum

Completed : Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
: Postmenopausal Osteoporosis
: 2005-09-12
:
  • Drug: menatetranone 15 mg thre

Completed : Study on the microRNA Expression Level in Postmenopausal Osteoporosis
: Postmenopausal Osteoporosis
: 2014-03-14
: Other: osteoporosis
Completed : Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
: Postmenopausal Osteoporosis
: 2011-07-29
: Other: Observation In this study we will examine the changes in bone density by DXA and QUS and bone tur
No longer available : A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
: Postmenopausal Osteoporosis
: 2007-06-27
: Drug: ibandronate [Bonviva/Boniva] 3mg iv every 3 months
Completed : BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
: Postmenopausal Osteoporosis
: 2007-10-16
:
  • Drug: ibandronate [Bonviva/Boniva]

Completed : A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
: Postmenopausal Osteoporosis
: 2007-10-16
: Drug: Ibandronate Participants will receive ibandronate 150 mg QM orally for 6 months.
Completed : A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis
: Postmenopausal Osteoporosis
: 2015-11-04
:
  • Drug: Alendronate Participants

Completed : Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
: Postmenopausal Osteoporosis
: 2006-11-29
: Drug: Ibandronate (SB743830HD)
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.